RESEARCHER PROFILE

Todd A. Alonzo

← Back to University of Southern California

T

University of Southern California

Acute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchRetinoids in leukemia and cellular processesCancer Genomics and DiagnosticsStatistical Methods in Epidemiology

Todd A. Alonzo works in Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Retinoids in leukemia and cellular processes, Cancer Genomics and Diagnostics, Statistical Methods in Epidemiology. Recorded institutional associations include University of Southern California, Children's Oncology Group.

698Publications
18,014Citations
73H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

    2017 · 848 citations
  2. Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

    2014 · 486 citations
  3. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

    2009 · 445 citations
  4. Clinical implications of FLT3 mutations in pediatric AML

    2006 · 395 citations
  5. The genomic landscape of juvenile myelomonocytic leukemia

    2015 · 301 citations
  6. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

    2012 · 297 citations
  7. Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

    2007 · 274 citations
  8. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor

    2011 · 257 citations
  9. Using a combination of reference tests to assess the accuracy of a new diagnostic test

    1999 · 240 citations
  10. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

    2011 · 231 citations
  11. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

    2007 · 231 citations
  12. The incidence and clinical significance of nucleophosmin mutations in childhood AML

    2007 · 216 citations
  13. Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

    2009 · 215 citations
  14. Distribution-free ROC analysis using binary regression techniques

    2002 · 203 citations
  15. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia

    2011 · 199 citations
  16. Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

    2010 · 186 citations
  17. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating: By Ewout W. Steyerberg

    2009 · 182 citations
  18. Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group

    2020 · 169 citations
  19. Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse

    2016 · 163 citations
  20. Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891

    2003 · 161 citations
  21. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update

    2008 · 159 citations
  22. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

    2013 · 156 citations
  23. Extramedullary Leukemia in Children With Newly Diagnosed Acute Myeloid Leukemia

    2003 · 156 citations
  24. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study

    2007 · 156 citations
  25. CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children’s Oncology Group Trial AAML0531

    2017 · 156 citations

← Return to the university profile